NDC properties for NDC 9 0054-0879
NDC item 00054087949
| NDC 9 | 0054-0879 |
|---|---|
| NDC 10 | 0054-0879-49 |
| NDC Item | 00054087949 |
| packaging | 1 BOTTLE, GLASS in 1 CARTON (0054-0879-49) / 100 mL in 1 BOTTLE, GLASS |
| ANDA | ANDA216418 |
| COLORTEXT | PINK(Pink to Brown) |
| Color | C48328 __ |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-06-16 |
| Marketing status | ACTIVE |
NDC item 00054458249
| NDC 9 | 0054-4582 |
|---|---|
| NDC 10 | 0054-4582-49 |
| NDC Item | 00054458249 |
| packaging | 1 BOTTLE, GLASS in 1 CARTON (0054-4582-49) / 100 mL in 1 BOTTLE, GLASS |
| ANDA | ANDA216418 |
| COLORTEXT | PINK(Pink to Brown) |
| Color | C48328 __ |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-26 |
| Marketing status | ACTIVE |
NDC item 62484102003
| NDC 9 | 62484-1020 |
|---|---|
| NDC 10 | 62484-1020-3 |
| NDC Item | 62484102003 |
| packaging | 100 mL in 1 BOTTLE |
| Labeler | Nova Laboratories, Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2025-09-08 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA205919 |
NDC item 62484102004
| NDC 9 | 62484-1020 |
|---|---|
| NDC 10 | 62484-1020-4 |
| NDC Item | 62484102004 |
| packaging | 1 BOTTLE in 1 CARTON (62484-1020-4) / 100 mL in 1 BOTTLE (62484-1020-3) |
| Labeler | Nova Laboratories, Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2025-09-08 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA205919 |